Diligence memo · auto-generated · as of July 2, 2026
D2 Pharma Consulting LLC
D2 Pharma Consulting LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
D2 Pharma Consulting LLC operates in Pharma, based in CHESTERFIELD.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
D2 Pharma Consulting LLC has raised $1.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.6M on 2022-12-28.
Most recent recorded round closed around 2022-12-28.
Valuation (modeled)modeled
Provath models D2 Pharma Consulting LLC at approximately $17M (range $1.2M–$67M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.23× the median modeled value of Seed Pharma companies in 2022–2024 (18 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 3.5 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 41% of Pharma peers (310 compared).
Modeled value ranks above 42% of those peers.
Closest niche peers: Seal Rock Therapeutics, Inc., Diligent Pharma, Inc., A28 Therapeutics, Inc., Centaurus Therapeutics, Inc., Pathfinder Oncology, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.